Pathyaപഥ്യം
← New record

IndiPGx-Read D-r11

Lab reportcohort · demo

10/30/2026, 6:26:46 AM · PharmCAT 3.4.0 · Research record, not medical advice

4
Genes standardised
4
Calls quoted
0
Coverage gaps
1
Identifiers removed
24.2s
Upload to record
  1. Muse Sparkread 4 gene calls12.9s
  2. PharmCATstandardised 4 genes11.3s
  3. Rules0 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Example Pharmacogenomics Centre, Mumbai · FOR SOFTWARE TESTING · 2 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
CYP2C19“CYP2C19 | Phenotype: Poor metabolizer | *2 | Detected (homozygous) | *3 | Not detected | *17 | Not detected”*2/*2Poor Metabolizer
CYP2D6“CYP2D6 | Phenotype: Normal metabolizer | *2 | Not detected | *3 | Not detected | *4 | Not detected | *5 | Not detected | *6 | Not detected | *10 | Not detected | *41 | Not detected”*1/*1Normal Metabolizer · activity 2.0
DPYD“DPYD | Phenotype: Normal metabolizer | c.1236G>A (HapB3) | Not detected | c.85T>C (*9A) | Detected (heterozygous) | c.1905+1G>A (*2A) | Not detected | c.1679T>G (*13) | Not detected | c.2846A>T | Not detected”Reference/c.85T>C (*9A)Normal Metabolizer · activity 2.0
TPMT“TPMT | Phenotype: Intermediate metabolizer | *2 | Not detected | *3A | Not detected | *3B | Not detected | *3C | Detected (heterozygous)”*1/*3CIntermediate Metabolizer

Method as printed: Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded.

Coveragedeterministic rules · which India-relevant variants this panel named

DPYDHapB3named on the report

Most common Indian decreased-function DPYD variant (~3.3%, PMID 40810747)

DPYDc.85T>C (*9A)named on the report

~25% in Indians; toxicity signal in South Indian cohorts (PMC11300675)

DPYD*2Anamed on the report

European tier-1 variant; rare in Indians (PMID 40810747)

DPYD*13named on the report

Tier-1 no-function variant (PMID 39032821)

DPYDc.2846A>Tnamed on the report

Tier-1 variant; near-absent in Indians (PMID 40810747)

TPMT*3Cnamed on the report

Most common TPMT variant in South Asians

CYP2C19*2named on the report

Common no-function allele in South Asians

CYP2C19*17named on the report

Increased-function allele

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. A patient or lab reference printed on the report was removed before storage. Reader notes: Only the listed variants are assayed; variants outside this panel cannot be excluded. CYP2D6 *1/*1 inferred from non-detection of tested alleles; untested variants cannot be excluded. Synthetic document generated for software benchmarking. Not a real patient or laboratory.

Exportde-identified · the same record in three formats

Curator review

This is a read-only sample. In the pilot, a curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log.

Sign in with the pilot code
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/ede30bd70e34/audit.log.